Shanghai World Leader Pharmaceutical
Organisation
Trials
A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
Phase 1, Recruiting, 60 people, 12 Mar 2026
Sources: clinicaltrials.gov
Organisation
A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
Phase 1, Recruiting, 60 people, 12 Mar 2026
Sources: clinicaltrials.gov